Sign In
Buy MED
$10.62
-0.400 (-3.63%)
At Close: Jun 23, 2026
Medifast, Inc. (MED) Q4 2024 Earnings Call Transcript
07:06pm, Tuesday, 18'th Feb 2025
Medifast, Inc. (NYSE:MED ) Q4 2024 Earnings Conference Call February 18, 2025 4:30 PM ET Company Participants Steven Zenker - Vice President, Investor Relations Dan Chard - Chairman and Chief Executiv
Medifast (MED) Q4 Earnings and Revenues Beat Estimates
06:56pm, Tuesday, 18'th Feb 2025
Medifast (MED) came out with quarterly earnings of $0.10 per share, beating the Zacks Consensus Estimate of a loss of $0.27 per share. This compares to earnings of $1.09 per share a year ago.
Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2024
04:05pm, Tuesday, 04'th Feb 2025
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, will announce financial results for the four
MED Focused on GLP-1 Solutions Amid Customer Acquisition Challenges
10:46am, Wednesday, 22'nd Jan 2025
With a strategic focus on innovation and a robust operational framework, Medifast is well-placed for growth in the weight loss and GLP-1 medication space.
Medifast Launches OPTAVIA ASCEND for Weight Loss Management
07:56am, Wednesday, 08'th Jan 2025
MED's new OPTAVIA ASCEND product line combines high-protein meals, fiber-rich nutrients and personalized coaching.
Medifast Introduces New High-Protein Product Line OPTAVIA ASCEND™ For GLP-1 Users & Those Looking for Help to Keep Weight Off
08:30am, Tuesday, 07'th Jan 2025
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE:MED), the health and wellness company known for its habit based and coach-guided lifestyle solution OPTAVIA, today announced OPTAVIA ASCEND — a new product
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA®, today shared findings from a recent independe
How Should You Play Medifast Stock at a P/E Multiple of 17.6X?
11:00am, Tuesday, 19'th Nov 2024
MED is battling customer acquisition challenges and high SG&A costs, while its strategic growth efforts keep it well-positioned for long-term success.
Are Investors Undervaluing MEDIFAST (MED) Right Now?
10:45am, Thursday, 07'th Nov 2024
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Medifast: Earnings Surprise, New AI Technologies, And Extremely Undervalued
08:02am, Wednesday, 06'th Nov 2024
Medifast reported better-than-expected quarterly EPS and is investing in new marketing strategies, AI technologies, and supply chain optimization to drive future growth. Despite a decline in the numbe
MED Q3 Earnings Beat, Revenues Fall on Customer Acquisition Challenges
07:35am, Tuesday, 05'th Nov 2024
Medifast's Q3 results lower earnings and revenues, highlighting challenges in customer acquisition. Management issues soft guidance for the fourth quarter.
Medifast (MED) Beats Q3 Earnings and Revenue Estimates
06:46pm, Monday, 04'th Nov 2024
Medifast (MED) came out with quarterly earnings of $0.35 per share, beating the Zacks Consensus Estimate of a loss of $0.15 per share. This compares to earnings of $2.12 per share a year ago.
Medifast, Inc. (MED) Q3 2024 Earnings Call Transcript
05:56pm, Monday, 04'th Nov 2024
Medifast, Inc. (NYSE:MED ) Q3 2024 Earnings Conference Call November 4, 2024 4:30 PM ET Company Participants Steven Zenker - Vice President-Investor Relations Dan Chard - Chairman & Chief Executive Of
Medifast Gears Up for Q3 Earnings: Here's What You Should Know
10:56am, Friday, 01'st Nov 2024
MED's Q3 results may reflect customer acquisition challenges and a decline in active earning OPTAVIA Coaches due to the increasing adoption of GLP-1 medications.
Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2024
04:05pm, Monday, 21'st Oct 2024
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, will announce financial results for the thir
